Free Newsletter

FEATURES >> 10 largest U.S. patent losses | 15 top blockbuster contenders | Emerging pharma jobs

Related Topics >> Merck

SPOTLIGHT: Tossing and turning? Maybe it's the Zocor

November 7, 2007 — 6:59am ET

Related Stories

Tools

Merck's cholesterol drug Zocor (simvastatin) may cause insomnia and other sleep disruptions, according to a new study that compared the remedy to its rival Pravachol, made by Bristol-Myers Squibb. Report

SHARE
WITH:

More stories about Merck

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>